접선유동여과 시장 규모, 점유율, 동향 및 예측 : 제품별, 기술별, 용도별, 최종사용자별, 지역별(2026-2034년)

The global tangential flow filtration market size was valued at USD 1.33 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 2.17 Billion by 2034, exhibiting a CAGR of 5.59% during 2026-2034. North America currently dominates the market, holding a market share of 40% in 2025. The growth of the market is attribute to the increasing demand for efficient separation and purification processes, rising adoption in biopharmaceutical and biotechnology industries, and the need for high-quality, scalable production. Advancements in filtration technology, growing focus on process optimization, and regulatory support for high-purity products further contribute to the expansion of the tangential flow filtration market share.

The growing employment of tangential flow filtration in the development of monoclonal antibodies, vaccines, recombinant proteins, and other biologics is a crucial factor influencing the market. As the worldwide demand for biologics continues to rise, manufacturers increasingly rely on efficient filtration solutions to concentrate, purify, and separate biomolecules. Tangential flow filtration provides scalability and high recovery rates, making them essential for large-scale production and driving the market demand. Furthermore, improvements in membrane technology, including better pore designs, increased chemical compatibility, and extended membrane durability, are improving the performance of these filtrating solutions. Contemporary membranes enable increased throughput, minimized fouling, and simpler cleaning, rendering it more economical and attractive for producers.

The United States is a crucial segment in the market, driven by continuous advancements in filtration membranes, including higher chemical resistance, longer lifespans, and improved pore structures. These innovations allow higher throughput, lower fouling, and easier cleaning, making it more cost-effective and efficient. Moreover, the increasing investment in state-of-the-art bioprocess facilities is bolstering the tangential flow filtration market growth, as advanced research, process development, and training capabilities enhance innovation, support next-generation therapeutics, and improve adoption of efficient filtration technologies across the biopharmaceutical industry. In 2024, Sartorius Stedim Biotech opened a new Center for Bioprocess Innovation in Marlborough, USA. The 63,000 sq. ft. facility supported next-generation therapeutics with labs for research, process development, demos, and training.

Tangential Flow Filtration Market Trends:

Growing Geriatric Population

The market is being driven by the increasing demand for biopharmaceuticals and therapeutics, owing to the aging global population. The World Health Organization (WHO) projects that by 2030, one in six individuals worldwide will be 60 years or older, rising to 2.1 billion by 2050. The population aged 80 and above is also expected to triple, reaching 426 million by 2050. This demographic shift leads to a higher prevalence of age-related and chronic diseases, catalyzing the demand for innovative treatments, biologics, and vaccines. To meet this demand, biopharmaceutical and biotechnology companies are adopting advanced tangential flow filtration that ensure high-purity, consistent, and scalable production of therapeutic products. The growing emphasis on reliable and efficient separation, concentration, and purification processes is influencing the market and encouraging ongoing innovation in filtration technologies to address the healthcare challenges of an aging population.

Sustainability and Operational Efficiency

Industries are focusing on technologies that decrease material waste, lower energy usage, and streamline operational processes. Systems created for simple setup and integration simplify workflows, decrease labor needs, and minimize error risks, leading to increased productivity. Furthermore, solutions that enhance resource efficiency and promote eco-friendly practices are in line with rising regulatory and corporate sustainability efforts. These advanced filtration systems provide operational efficiency while maintaining performance and product quality, addressing the changing needs of biopharmaceutical and biotechnology industries. As a result, the focus on sustainability and efficiency is offering a favorable tangential flow filtration market outlook. In 2024, Sartorius launched the Vivaflow(R) SU, a next-generation tangential flow filtration cassette designed for ultrafiltration of 100-1,000 mL volumes. It offered easy setup, improved efficiency, and uses 30.5% less plastic, promoting sustainability in research labs. The all-in-one design worked with standard lab pumps, eliminating complex setup and cleaning steps.

Advancements in Flexibility and Process Control

Producers are looking for options that can be readily adjusted to different production levels and intricate bioprocessing needs while ensuring uniform product quality. Enhanced system adaptability enables smooth incorporation into various workflows, minimizing downtime and operational inefficiencies. Improved control functionalities facilitate precise oversight of filtration metrics, allowing for optimized separation, concentration, and purification operations. These features lead to enhanced productivity, minimized waste, and economical operations. As industries focus more on optimizing processes, scalability, and reliability, the use of advanced filtration featuring adaptable and controllable designs is on the rise, contributing to the market growth and fostering innovation in bioprocessing solutions. In 2024, Tezalon Biotech launched its Modular TFF Benchtop System, offering enhanced flexibility and control for tangential flow filtration processes. The system was designed to optimize bioprocessing workflows with seamless adaptability and user-friendly operation.

Tangential Flow Filtration Industry Segmentation:

Analysis by Product:

• Single-Use Tangential Flow Filtration Systems
• Reusable Tangential Flow Filtration Systems
• Membrane Filters
• Filtration Accessories

Single-use tangential flow filtration systems exhibit a clear dominance in the market with a share of 38.2%, because of their operational efficiency, adaptability, and lower risk of cross-contamination. These systems come pre-assembled and prepared for use, reducing setup duration and streamlining process validation. Their throwaway characteristic removes the requirement for extensive sanitization and cleaning, boosting efficiency and assuring adherence to strict regulatory guidelines. They also enable quicker transitions between production batches, making them ideal for biopharmaceutical applications where flexibility and rapidity are essential. Single-use systems facilitate smooth scaling and are especially beneficial in multi-product environments that need regular process adjustments. Their compact design aids in optimizing space and reduces the total expenses linked to maintenance and facility infrastructure. Moreover, they correspond with contemporary manufacturing methods that stress efficiency, reliability, and uniform product quality, strengthening their increasing preference in research, clinical, and commercial bioprocessing settings.

Analysis by Technology:

• Microfiltration
• Ultrafiltration
• Reverse Osmosis
• Nano Filtration

Ultrafiltration holds the biggest market share of 57.5%, attributed to its efficiency, accuracy, and flexibility in separating and concentrating biomolecules. This technology ensures dependable performance in eliminating contaminants while maintaining the quality and integrity of target products, making it exceptionally suitable for various uses in the biopharmaceutical and biotechnology fields. Ongoing improvements in ultrafiltration membrane and system configuration are increasing scalability, throughput, and operational effectiveness, promoting wider acceptance. The technology furthers aids in optimizing processes by cutting down processing time, decreasing waste, and guaranteeing uniform product results. The focus on product safety and quality regulations further encourages the adoption of ultrafiltration as a reliable technique for obtaining high-purity outcomes. In addition, its flexibility for different production scales and alignment with intricate biological solutions enhances its significance in contemporary manufacturing.

Analysis by Application:

• Bioprocess Applications
  • Upstream Processing
  • Downstream Processing
• Viral Vector and Vaccine Purification
• Others

Bioprocess applications (upstream processing and downstream processing) dominate the market with 35%, because of the increasing demand for effective and dependable separation, concentration, and purification methods in biological production. These applications need high-quality, scalable solutions to uphold consistency and guarantee product integrity during different phases of bioprocessing. The rising investment in biopharmaceutical research activities is driving the need for advanced filtration systems capable of accurately managing intricate biomolecules. Emphasis on enhancing processes, increasing operational efficiency, and ensuring cost-effectiveness propels the use of advanced filtration technologies. Furthermore, the regulatory focus on product safety, quality, and reproducibility is encouraging the adoption of strong filtration technologies. The capability to simplify workflows, decrease processing time, and boost overall productivity further contributes to the market growth of this segment.

Analysis by End User:

• Pharmaceutical and Biotechnological Companies
• Academic and Research Institutes
• Contract Research Organizations

Pharmaceutical and biotechnological companies represent the largest segment, accounting for 55% market share, attributed to their rising emphasis on high-purity products, effective separation processes, and scalable production needs. These sectors emphasize implementing cutting-edge filtration technologies to guarantee uniform quality, dependability, and adherence to strict regulatory requirements. Furthermore, the growing research and development (R&D) efforts in drug creation, biologics, and therapeutic options are driving the need for efficient filtration solutions. Firms in these industries are focusing on process improvement to boost operational efficiency, shorten production time, and ensure cost-effectiveness. The focus on innovation, accuracy, and consistency in manufacturing processes promotes the incorporation of advanced filtration technologies. In addition, the increasing recognition about the significance of process management and product safety is fostering the broad implementation of tangential flow filtration.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market with a share of 40%, owing to its robust technological foundation and advanced expertise in biopharmaceutical and biotechnology production. The region benefits from significant investment in research, fostering innovation in filtration solutions that enhance efficiency, scalability, and product quality. Supportive regulatory frameworks and established quality benchmarks create an environment conducive to adopting high-performance filtration solutions. The presence of key market participants, which are continuously innovations, is further strengthening the market growth of the region. For instance, in 2025, Asahi Kasei Bioprocess America won the Best Technologies Innovation Award at INTERPHEX 2025 for its THESYS(R) Cleavage & Deprotection (C&D) and tangential flow filtration unit. This integrated system improves oligonucleotide manufacturing by combining two processes into one, boosting efficiency and space savings. Additionally, increasing emphasis on process optimization, cost efficiency, and product purity fosters widespread adoption of filtration technologies.

Key Regional Takeaways:

United States Tangential Flow Filtration Market Analysis

In North America, the market portion held by the United States was 85%, attributed to the growing incidence of acute and chronic illnesses. For example, 6 in 10 Americans suffer from a chronic disease, and 4 in 10 have two or more chronic diseases, which make up ninety percent of the annual health care expenses totaling USD 4.5 Trillion in the country. The rise in cardiovascular, respiratory, and metabolic diseases is catalyzing the demand for sophisticated bioprocessing methods to facilitate large-scale manufacturing of biologics and therapeutic products. Tangential flow filtration is becoming an essential technique for separation and purification in clinical and research environments. Apart from this, the rising emphasis on efficient, scalable filtration systems aligns with the growing need to handle complex biopharmaceutical formulations and enhance therapeutic development processes. Healthcare providers and biotech companies are progressively adopting this technology to guarantee quality and adherence throughout production phases

Europe Tangential Flow Filtration Market Analysis

Europe is witnessing a rise in the market demand owing to the increasing elderly population. The WHO states that the number of individuals aged 60 and above is increasing swiftly in the WHO European Region. In 2021, there were 215 million, and it is estimated that by 2030, this will rise to 247 million, and in 2050, exceed 300 million. As the aging population becomes more vulnerable to chronic diseases like cancer, arthritis, and neurodegenerative disorders, there is an increase in dependence on biopharmaceutical treatments. Tangential flow filtration facilitates the efficient and scalable purification of these biologics, ensuring quicker patient delivery. As the healthcare system evolves to address the intricate medical requirements of the elderly, the production of biologics gains from sophisticated filtration methods. These trends are reflected in the tangential flow filtration market forecast, with significant growth expected in the coming years, driven by the increasing demand for high-quality biopharmaceuticals in the aging population.

Asia Pacific Tangential Flow Filtration Market Analysis

The market growth in the Asia-Pacific region is because of the growing investment in the pharmaceutical industry. As per the India Brand Equity Foundation (IBEF), the Government of India has designated Rs. 99,858 crore (USD 11.50 Billion) allocated to the healthcare sector in the Union Budget 2025-26 for the improvement, upkeep, and advancement of the nation's healthcare system. The rising investment in the creation of vaccines, biosimilars, and biologics is resulting in improved implementation of filtration systems throughout manufacturing facilities. Tangential flow filtration facilitates high-throughput and consistent purification, meeting the efficiency needs of the growing pharmaceutical production processes. The area's developing pharmaceutical framework requires creative, dependable solutions for the separation and concentration of biomolecules. Moreover, partnerships between local manufacturers and international biotech companies have boosted the adoption of this technology.

Latin America Tangential Flow Filtration Market Analysis

Latin America is experiencing greater investment and governmental backing in the healthcare industry, aiding the uptake of tangential flow filtration technologies. For example, funding for Brazil's Unified Health System is projected to rise by 6.2% in 2025. Enhancements in healthcare infrastructure, coupled with funding from both government and private sectors, are boosting biologics production capabilities. As therapeutic demands increase, filtration solutions are becoming essential for ensuring product quality and adhering to regulatory standards.

Middle East and Africa Tangential Flow Filtration Market Analysis

The Middle East and Africa are witnessing an increase in the adoption of tangential flow filtration driven by the growth of healthcare facilities and continuing privatization. For example, the healthcare sector in Saudi Arabia is undergoing unparalleled privatization under Vision 2030, with more than 290 hospitals and 2,300 health facilities moving to private management. With the expansion of medical centers and diagnostic labs in the region, there is a rise in the need for effective bioprocessing techniques. Tangential flow filtration guarantees superior biomolecule purification, supporting therapeutic advancements and clinical studies.

Competitive Landscape:

Major participants in the market are concentrating on innovation and technology improvements to boost filtration efficiency and product quality. They are allocating resources towards research operations to create scalable, high-efficiency solutions that align with changing industry demands. Strategic alliances and partnerships are being sought to broaden market access and enhance global footprint. Businesses are increasingly focusing on client-centered strategies, providing customized solutions and extensive support to enhance process results. Moreover, ongoing initiatives are being implemented to enhance cost-effectiveness and operational efficiency, securing a competitive edge. In 2025, Cytiva launched the AKTA readyflux(TM) TFF system 500, a new product designed for efficient small-scale drug manufacturing. It supports development of therapeutics like mRNA, viral vectors, and monoclonal antibodies with features like scalability, batch consistency, and ease of use. The filtration aims to speed up drug development while reducing resource demands.

The report provides a comprehensive analysis of the competitive landscape in the tangential flow filtration market with detailed profiles of all major companies, including:

• Andritz AG
• Cole-Parmer Instrument Company LLC
• Danaher Corporation
• General Electric Company
• Koch Separation Solutions (Koch Industries Inc.)
• Merck KGaA
• Novasep
• Parker-Hannifin Corporation
• Repligen Corporation
• Sartorius AG
• Solaris Biotechnology Srl
• Synder Filtration Inc.

Key Questions Answered in This Report

• 1.How big is the tangential flow filtration market?
• 2.What is the future outlook of tangential flow filtration market?
• 3.What are the key factors driving the tangential flow filtration market?
• 4.Which region accounts for the largest tangential flow filtration market share?
• 5.Which are the leading companies in the global tangential flow filtration market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Tangential Flow Filtration Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Single-Use Tangential Flow Filtration Systems
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Reusable Tangential Flow Filtration Systems
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Membrane Filters
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Filtration Accessories
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Microfiltration
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Ultrafiltration
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Reverse Osmosis
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Nano Filtration
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Application

• 8.1 Bioprocess Applications
  • 8.1.1 Market Trends
  • 8.1.2 Key Segments
    • 8.1.2.1 Upstream Processing
    • 8.1.2.2 Downstream Processing
  • 8.1.3 Market Forecast
• 8.2 Viral Vector and Vaccine Purification
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Pharmaceutical and Biotechnological Companies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic and Research Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Contract Research Organizations
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Alfa Laval AB
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Andritz AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Cole-Parmer Instrument Company LLC
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Danaher Corporation
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 General Electric Company
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Koch Separation Solutions (Koch Industries Inc.)
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 SWOT Analysis
  • 15.3.7 Merck KGaA
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Novasep
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Parker-Hannifin Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Repligen Corporation
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
  • 15.3.11 Sartorius AG
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 Solaris Biotechnology Srl
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
  • 15.3.13 Synder Filtration Inc.
    • 15.3.13.1 Company Overview
    • 15.3.13.2 Product Portfolio